Human CMP-N-acetylneuraminic acid hydroxylase is a novel stem cell marker linked to stem cell-specific mechanisms

Stem Cells

Volumn 28, Issue 2, 2010, Pages 258-267

  Nystedt, Johanna ^a   Anderson, Heidi ^a   Hirvonen, T I A ^a   Impola, Ulla ^a   Jaatinen, Taina ^a   Heiskanen, Annamari ^b   Blomqvist, Maria ^b   Satomaa, Tero ^b   Natunen, Jari ^b   Saarinen, Juhani ^b   Lehenkari, Petri ^c   Valmu, Leena ^a   Laine, Jarmo ^a  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

^b GLYKOS FINLAND LTD   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

CMP N acetylneuraminic acid hydroxylase; N glycolylneuraminic acid; Neu5GC; Stem cells; Wnt; Xenoantigen

Indexed keywords

BETA CATENIN; CELL MARKER; CYTIDINE PHOSPHATE N ACYLNEURAMINATE PHOSPHODIESTERASE; MESSENGER RNA;

ARTICLE; CELL POPULATION; CELL SPECIFICITY; CONTROLLED STUDY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MESENCHYME CELL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; UPREGULATION;

BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MIXED FUNCTION OXYGENASES; NEURAMINIC ACIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIALIC ACIDS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STEM CELLS;

EID: 77149167804     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.250     Document Type: Article

References (46)

1. Lanctot PM, Gage FH, Varki AP. The glycans of stem cells. Curr Opin Chem Biol 2007;11:373-380.
2. Varki NM, Varki A. Diversity in cell surface sialic acid presentations: Implications for biology and disease. Lab Invest 2007;87:851-857.
3. Schauer R, ed. Sialic acids: Chemistry, metabolism and function. In: Cell Biology Monographs, Vol 10. New York: Springer, 1982:5-39.
4. Kelm S, Schauer R. Sialic acids in molecular and cellular interactions. Int Rev Cytol 1997;175:137-240.
5. Angata T, Varki A. Chemical diversity in the sialic acids and related alpha-keto acids: An evolutionary perspective. Chem Rev 2002;102:439-469.
6. Schauer R, Wember M. Hydroxylation and O-acetylation of N-acetylneuraminic acid bound to glycoproteins of isolated subcellular membranes from porcine and bovine submaxillary glands. Hoppe Seylers Z Physiol Chem 1971;352:1282-1290.
7. Buscher HP, Casals-Stenzel J, Schauer R et al. Biosynthesis of N-glycolylneuraminic acid in porcine submandibular glands. Subcellular site of hydroxylation of N-acetylneuraminic acid in the course of glycoprotein biosynthesis. Eur J Biochem 1977;77:297-310.
8. Shaw L, Schauer R. The biosynthesis of N-glycoloylneuraminic acid occurs by hydroxylation of the CMP-glycoside of N-acetylneuraminic acid. Biol Chem Hoppe Seyler 1988;369:477-486.
9. Kawano T, Koyama S, Takematsu H et al. Molecular cloning of cytidine monophospho-N-acetylneuraminic acid hydroxylase. Regulation of species-and tissue-specific expression of N-glycolylneuraminic acid. J Biol Chem 1995;7:270:16458-16463.
10. Muchmore EA, Diaz S, Varki A. A structural difference between the cell surfaces of humans and the great apes. Am J Phys Anthropol 1998;107:187-198.
11. Chou HH, Takematsu H, Diaz S et al. A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci U S A 1998;95:11751-11756.
12. Irie A, Koyama S, Kozutsumi Y et al. The molecular basis for the absence of N-glycolylneuraminic acid in humans. J Biol Chem 1998;273:15866-15871.
13. Chou HH, Hayakawa T, Diaz S et al. Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution. Proc Natl Acad Sci U S A 2002;99:11736-11741.
14. Hayakawa T, Aki I, Varki A et al. Fixation of the human-specific CMPN-acetylneuraminic acid hydroxylase pseudogene and implications of haplotype diversity for human evolution. Genetics 2006;172:1139-1146.
15. Hayakawa T, Satta Y, Gagneux P et al. Alu-mediated inactivation of the human CMP- N-acetylneuraminic acid hydroxylase gene. Proc Natl Acad Sci U S A 2001;98:11399-11404.
16. Tangvoranuntakul P, Gagneux P, Diaz S et al. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci U S A 2003;100:12045-12050.
17. Bardor M, Nguyen DH, Diaz S et al. Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells. J Biol Chem 2005;280:4228-4237.
18. Merrick JM, Zadarlik K, Milgrom F. Characterization of the Hanganutziu-Deicher (serum-sickness) antigen as gangliosides containing n-glycolylneuraminic acid. Int Arch Allergy Appl Immunol 1978;57:477-580.
19. NguyenDH, Tangvoranuntakul P, VarkiA. Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells. J Immunol 2005;175:228-236.
20. Padler-Karavani V, Yu H, Cao H et al. Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: Potential implications for disease. Glycobiology 2008;18:818-830.
21. Hedlund M, Tangvoranuntakul P, Takematsu H et al. N-glycolylneuraminic acid deficiency in mice: Implications for human biology and evolution. Mol Cell Biol 2007;27:4340-4346.
22. Martin MJ, Muotri A, Gage F et al. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 2005;11:228-232.
23. Heiskanen A, Satomaa T, Tiitinen S et al. N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells 2007;25:197-202.
24. Jaatinen T, Hemmoranta H, Hautaniemi S et al. Global gene expression profile of human cord blood-derived CD133+ cells. Stem Cells 2006;24:631-641.
25. Kekarainen T, Mannelin S, Laine J et al. Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells. BMC Cell Biol 2006;1:7:30.
26. Laitinen A, Laine J. Isolation of mesenchymal stem cells from human cord blood. Curr Protoc Stem Cell Biol 2007;Chapter 2:Unit 2A.3.
27. Leskelä HV, Risteli J, Niskanen S et al. Osteoblast recruitment from stem cells does not decrease by age at late adulthood. Biochem Biophys Res Commun 2003;311:1008-1013.
28. Sambrook J, Russell DW, eds. Molecular Cloning: A Laboratory Manual, Third Edition. New York: Cold Spring Harbor Laboratory Press, 2001.
29. Naito Y, Takematsu H, Koyama S et al. Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation. Mol Cell Biol 2007;27:3008-3022.
30. Schulze YN. Potential mechanism of biosynthesis of N-glycolyneuraminic acid in human tissues. 2008; Congress abstract, SialoGlyco Conference.
31. Malykh YN, King TP, Logan E et al. Regulation of N-glycolylneuraminic acid biosynthesis in developing pig small intestine. Biochem J 2003;370:601-607.
32. van der Merwe PA, Crocker PR, VinsonMet al. Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22. J Biol Chem 1996;271:9273-9280.
33. Muchmore EA, Milewski M, Varki A et al. Biosynthesis of N-glycolyneuraminic acid. The primary site of hydroxylation of N-acetylneuraminic acid is the cytosolic sugar nucleotide pool. J Biol Chem 1989;264:20216-20223.
34. Reya T, Duncan AW, Ailles L et al. A role for Wnt signaling in selfrenewal of haematopoietic stem cells. Nature 2003;423:409-414.
35. Marson A, Foreman R, Chevalier B et al. Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 2008;3:132-135.
36. Duncan AW, Rattis FM, DiMascio LN et al. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 2005;6:314-322.
37. Katoh M. WNT signaling in stem cell biology and regenerative medicine. Curr Drug Targets 2008;9:565-570.
38. Reya T. Regulation of hematopoietic stem cell self-renewal. Recent Prog Horm Res 2003;58:283-295.
39. Willert K, Brown JD, Danenberg E et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 2003;423:448-452.
40. Reya T, Clevers H. Wnt signaling in stem cells and cancer. Nature 2005;434:843-850.
41. Reguart N, He B, Taron M. The role of Wnt signaling in cancer and stem cells. Future Oncol 2005;1:787-797.
42. Gordon MD, Nusse R. Wnt signaling: Multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 2006;281:22429-22433.
43. Sampathkumar SG, Li AV, Jones MB et al. Metabolic installation of thiols into sialic acid modulates adhesion and stem cell biology. Nat Chem Biol 2006;2:149-152.
44. Kontou M, Bauer C, Reutter W et al. Sialic acid metabolism is involved in the regulation of gene expression during neuronal differentiation of PC12 cells. Glycoconj J 2008;25:237-244.
45. Hemmoranta H, Satomaa T, Blomqvist M et al. N-glycan structures and associated gene expression reflect the characteristic N-glycosylation pattern of human hematopoietic stem and progenitor cells. Exp Hematol 2007;35:1279-1292.
46. Heiskanen A, Hirvonen T, Salo H et al. Glycomics of bone marrowderived mesenchymal stem cells can be used to evaluate their cellular differentiation stage. Glycoconj J 2008;26:367-384.